Louise St-Onge

Head of Market Access and Government Affairs

Mitsubishi Tanabe Pharma Canada

Louise St-Onge is the Head of Market Access and Government Affairs at Mitsubishi Tanabe Pharma Canada.  She holds >25 years executive experience track record of strong contribution and achievement of commercial objectives in rare diseases, specialty therapeutic areas within both startup biotech and large pharma.  Experienced in Sales, Marketing, Market Access & Government Affairs, including several product launches she brings to the table a broad perspective. Louise is recognized for her strong leadership capabilities in guiding diverse teams/groups and she bares a solid business acumen that allows her to look at problems from multiple points of view and formulate ideas that have not previously been tested.


All Sessions by Louise St-Onge

Printer Friendly See Full Agenda

Agenda: Day 1 Oct 5, 2020

12:30 pm

12:30 pm

Panel Discussion: RARE DISEASE MARKET OUTLOOK

Paving the Way Forward for Rare Disease Therapies with Lessons Learned from COVID-19

Health Canada is preparing to implement a national strategy to help fund high-cost drugs for rare diseases by 2022–2023. How can you best prepare, and what can we learn from the COVID-19 vaccine journey? Inform your market access strategy with the experience of these market leaders. Establish your game plan by:

  • Determining the types of partnerships and funding that will be key to the successful development of drugs for rare diseases
  • Analyzing the impact of recently increased government funding on the overall treatment pipeline
  • Visualizing potential safe and expeditious routes to commercialization for these medicines

Chart a course to succeed in the new market access model for rare disease therapies

Agenda: Day 2 Oct 6, 2020